ACCP has some preferred shares outstanding but not many options. I cannot believe ACCP is so undervalued. First it has just started U.S. Mugard sales, then it has ProLindac chemotherapy drug in its pipeline and most recently they found a partner for its oral insulin. They also have oral hGH that needs a partner and several other drugs they are working to find oral formulations for. The potential of Mugard, Oral insulin and Prolindac should have this company valued alot higher then $80 million dollars.
you are so very right- I believe that some options do exist but they are small in number with a short time frame and $25.oo a share comes to mind ( but not sure about the 25) spoke to the cfo last year and he said the options were out of the money and he was not concened. IMHO we are all frustrated with the current pps/mkt cap and are waiting for some real news from davis and co. not like the dec 14th agreement. I believe that if I sell i will regret it. GLTA longs